Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Thursday, April 27, 2017

FDA Approves Brineura™ (cerliponase alfa) for the Treatment of CLN2 Disease, a Form of Batten Disease and Ultra-Rare Pediatric Brain Disorder in Children

http://www.biomarin.com

SAN RAFAEL, Calif., April 27, 2017 /PRNewswire/ — BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that the U.S. Food and Drug Administration (FDA) approved Brineura™ (cerliponase alfa) to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older…

April 27, 2017 at 10:49PM

http://ift.tt/2oQh50t

from

http://ift.tt/2oQh50t


Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)